Categories: Technology

CarMax Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against CarMax, Inc. – KMX

NEW ORLEANS, Dec. 18, 2025 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against CarMax, Inc. (NYSE: KMX), if they purchased or otherwise acquired the Company’s securities between June 20, 2025 and November 5, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Maryland.

Get Help

CarMax investors should visit us at https://www.claimsfiler.com/cases/nyse-kmx-1 or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

CarMax and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On September 25, 2025, the Company announced its Second Quarter Fiscal Year 2026 financial results, disclosing among other things, that retail unit sales had decreased 5.4%, comparable store unit sales had decreased 6.3%, wholesale units had decreased 2.2%, and that net earnings per diluted share of $0.64 compared to $0.85 a year ago.

On this news, the price of CarMax’s shares fell $11.5 per share, or 20.07%, to close at $45.60 per share on September 25, 2025.

The case is Cap v. CarMax, Inc., No. 25-cv-03602.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

GlobeNews Wire

Recent Posts

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical…

54 minutes ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement COPENHAGEN, Denmark; February 20, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance…

54 minutes ago

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

February 20, 2026 09:05 ET  | Source: Ernexa Therapeutics Inc. Live video webcast with Sanjeev…

54 minutes ago

First Responder Beyond Borders: Indian Navy’s Humanitarian Outreach in the Indian Ocean Region

VISAKHAPATNAM, India, Feb. 20, 2026 /PRNewswire/ -- The Indian Navy hosted the 9th edition of…

3 hours ago

Building India’s EdTech and AI Roadmap for Equitable Learning for Every Child

Central Square Foundation (CSF) hosted the EdTech and AI Convening - Education Dialogues, a satellite…

3 hours ago

GCCs to drive up to 50% of India office demand; US to dominate while UK & EU to gain share- says Colliers India

US firms account for close to 70% of GCC leasing activity since 2020, followed by EU…

3 hours ago